SGLT inhibitors for type 1 diabetes require more study

In this video exclusive, Mohammad El-rifai, MD, an endocrinologist at Cheyenne Regional Medical Center, describes the benefits and risks of using SGLT inhibitors in type 1 diabetes.

Source: VIDEO: SGLT inhibitors for type 1 diabetes require more study

About the Author

Stephanie Figon, MS, RDN, LD

Founder of NutriScape.NET. As a dietitian since 1992, Steph Figon has had experiences in consulting, 15 years in clinical, and has operated a private practice nutrition counseling office for since 2011. Connect on Linkedin

Tags:

Related Posts